Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective

Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects

(2018) Pavlos Msaouel et al.   CURRENT CANCER DRUG TARGETS

Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain

(2017) Anthony N. van den Pol et al.   JOURNAL OF VIROLOGY

Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways

(2016) U.D. Kahlert et al.   INTERNATIONAL JOURNAL OF CANCER

The Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) Protein

(2016) Liang-Tzung Lin et al.   Viruses-Basel

Retargeting Strategies for Oncolytic Herpes Simplex Viruses

(2016) Gabriella Campadelli-Fiume et al.   Viruses-Basel

Measles to the Rescue: A Review of Oncolytic Measles Virus

(2016) Sarah Aref et al.   Viruses-Basel

CD133 in brain tumor: the prognostic factor

(2016) Bin Li et al.   Oncotarget

CD133, Selectively Targeting the Root of Cancer

(2016) Jörg Schmohl et al.   Toxins

Oncolytic Viruses: Therapeutics With an Identity Crisis

(2016) Caroline J. Breitbach et al.   EBioMedicine

Effective Eradication of Glioblastoma Stem Cells by Local Application of an AC133/CD133-Specific T-cell–Engaging Antibody and CD8 T Cells

(2015) Shruthi Prasad et al.   CANCER RESEARCH

Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells

(2015) C. Venugopal et al.   CLINICAL CANCER RESEARCH

Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells

(2015) SHUN YAMAMURO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis

(2015) Bin Wu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Lassa-Vesicular Stomatitis Chimeric Virus Safely Destroys Brain Tumors

(2015) Guido Wollmann et al.   JOURNAL OF VIROLOGY

High CD133 Expression Is Associated with Worse Prognosis in Patients with Glioblastoma

(2015) Wei Zhang et al.   MOLECULAR NEUROBIOLOGY

CD105 Is a Surface Marker for Receptor-Targeted Gene Transfer into Human Long-Term Repopulating Hematopoietic Stem Cells

(2015) Sarah-Katharina Kays et al.   STEM CELLS AND DEVELOPMENT

Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis

(2015) Chen Zhong et al.   TUMOR BIOLOGY

Measles Fusion Machinery Is Dysregulated in Neuropathogenic Variants

(2015) Eric M. Jurgens et al.   mBio

First oncolytic virus approved for melanoma immunotherapy

(2015) Jonathan Pol et al.   OncoImmunology

Oncolytic potency of HER-2 retargeted VSV-FH hybrid viruses: the role of receptor ligand affinity

(2015) Camilo Ayala Breton et al.   Molecular Therapy-Oncolytics

Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57

(2015) Xuekai Zhu et al.   Oncotarget

Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency

(2014) A. Muik et al.   CANCER RESEARCH

Faster Replication and Higher Expression Levels of Viral Glycoproteins Give the Vesicular Stomatitis Virus/Measles Virus Hybrid VSV-FH a Growth Advantage over Measles Virus

(2014) C. Ayala-Breton et al.   JOURNAL OF VIROLOGY

Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy

(2014) Stephen J. Russell et al.   MAYO CLINIC PROCEEDINGS

Interferon-  Induces Loss of Spherogenicity and Overcomes Therapy Resistance of Glioblastoma Stem Cells

(2014) C. Happold et al.   MOLECULAR CANCER THERAPEUTICS

Specific Elimination of CD133+ Tumor Cells with Targeted Oncolytic Measles Virus

(2013) P. Bach et al.   CANCER RESEARCH

An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis

(2013) J Lampe et al.   GENE THERAPY

Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas

(2013) Jung Ha Shin et al.   JOURNAL OF NEURO-ONCOLOGY

Amalgamating Oncolytic Viruses to Enhance Their Safety, Consolidate Their Killing Mechanisms, and Accelerate Their Spread

(2013) Camilo Ayala-Breton et al.   MOLECULAR THERAPY

DARPin-targeting of Measles Virus: Unique Bispecificity, Effective Oncolysis, and Enhanced Safety

(2013) Katrin Friedrich et al.   MOLECULAR THERAPY

Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine

(2012) Tomomi Hayashi et al.   CANCER SCIENCE

Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer

(2012) E. Hastie et al.   JOURNAL OF GENERAL VIROLOGY

Mutant Fusion Proteins with Enhanced Fusion Activity Promote Measles Virus Spread in Human Neuronal Cells and Brains of Suckling Hamsters

(2012) S. Watanabe et al.   JOURNAL OF VIROLOGY

Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software

(2011) Lee Kamentsky et al.   BIOINFORMATICS

The critical role of CD133+CD44+/high tumor cells in hematogenous metastasis of liver cancers

(2011) Ying Hou et al.   CELL RESEARCH

Targeting Tumor-Initiating Cancer Cells with dCD133KDEL Shows Impressive Tumor Reductions in a Xenotransplant Model of Human Head and Neck Cancer

(2011) N. N. Waldron et al.   MOLECULAR CANCER THERAPEUTICS

Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity

(2010) M. Hoffmann et al.   JOURNAL OF GENERAL VIROLOGY

Peripheral Immunization Blocks Lethal Actions of Vesicular Stomatitis Virus within the Brain

(2009) K. Ozduman et al.   JOURNAL OF VIROLOGY

Toxicology Study of Repeat Intracerebral Administration of a Measles Virus Derivative Producing Carcinoembryonic Antigen in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas

(2008) Rae Myers et al.   HUMAN GENE THERAPY